Share on StockTwits

PAREXEL International (NASDAQ:PRXL) COO Mark A. Goldberg unloaded 16,761 shares of PAREXEL International stock in a transaction that occurred on Wednesday, August 13th. The shares were sold at an average price of $56.33, for a total transaction of $944,147.13. Following the sale, the chief operating officer now directly owns 105,088 shares of the company’s stock, valued at approximately $5,919,607. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Several analysts have recently commented on the stock. Analysts at Sterne Agee raised their price target on shares of PAREXEL International from $36.00 to $42.00 in a research note on Friday, August 8th. Separately, analysts at Robert W. Baird raised their price target on shares of PAREXEL International from $64.00 to $66.00 in a research note on Thursday, August 7th. They now have an “outperform” rating on the stock. Finally, analysts at Jefferies Group raised their price target on shares of PAREXEL International from $58.00 to $59.00 in a research note on Thursday, August 7th. They now have a “hold” rating on the stock. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $56.63.

Shares of PAREXEL International (NASDAQ:PRXL) traded up 1.91% on Thursday, hitting $57.67. The stock had a trading volume of 310,785 shares. PAREXEL International has a 52 week low of $37.53 and a 52 week high of $57.81. The stock’s 50-day moving average is $54.25 and its 200-day moving average is $52.00. The company has a market cap of $3.280 billion and a P/E ratio of 25.15.

PAREXEL International (NASDAQ:PRXL) last released its earnings data on Thursday, August 7th. The company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.62 by $0.03. The company had revenue of $510.60 million for the quarter, compared to the consensus estimate of $508.99 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The company’s revenue for the quarter was up 10.3% on a year-over-year basis. Analysts expect that PAREXEL International will post $2.69 EPS for the current fiscal year.

PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.